Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Aversa

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|January 1, 1991
Results of T-depleted BMT in chronic myelogenous leukaemia after a conditioning regimen that included thiotepaF Aversa, P G Pelicci, A Terenzi, et al.
Bone Marrow Transplantation|December 1, 1989
Immunological reconstitution after HLA-haploidentical bone marrow transplantation for SCID in an infant with ADA deficiencyA Lanfranchi, L Nespoli, F Porta, et al.
Lancet (London, England)|May 16, 1992
Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxinB Falini, A Bolognesi, L Flenghi, et al.
Blood|November 9, 2000
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantationD Cilloni, C Carlo-Stella, F Falzetti, et al.
Bone Marrow Transplantation|December 6, 2011
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCTK Perruccio, F Topini, A Tosti, et al.
Blood|April 6, 2001
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI Volpi, K Perruccio, A Tosti, et al.
Blood|November 15, 1993
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation GroupW Arcese, J M Goldman, E D'Arcangelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)M Rummel, T M Kim, F Aversa, et al.
Infection|November 1, 1986
Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazoleF Menichetti, A Del Favero, R Guerciolini, et al.
Haematologica|April 29, 1998
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrowW Arcese, F Aversa, G Bandini, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|January 1, 1991
Results of T-depleted BMT in chronic myelogenous leukaemia after a conditioning regimen that included thiotepaF Aversa, P G Pelicci, A Terenzi, et al.
Bone Marrow Transplantation|December 1, 1989
Immunological reconstitution after HLA-haploidentical bone marrow transplantation for SCID in an infant with ADA deficiencyA Lanfranchi, L Nespoli, F Porta, et al.
Lancet (London, England)|May 16, 1992
Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxinB Falini, A Bolognesi, L Flenghi, et al.
Blood|November 9, 2000
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantationD Cilloni, C Carlo-Stella, F Falzetti, et al.
Bone Marrow Transplantation|December 6, 2011
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCTK Perruccio, F Topini, A Tosti, et al.
Blood|April 6, 2001
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI Volpi, K Perruccio, A Tosti, et al.
Blood|November 15, 1993
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation GroupW Arcese, J M Goldman, E D'Arcangelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)M Rummel, T M Kim, F Aversa, et al.
Infection|November 1, 1986
Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazoleF Menichetti, A Del Favero, R Guerciolini, et al.
Haematologica|April 29, 1998
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrowW Arcese, F Aversa, G Bandini, et al.
Pageof 11